Liu L, He H, Du B, He Y
RSC Adv. 2025; 15(6):4031-4078.
PMID: 39926227
PMC: 11803502.
DOI: 10.1039/d4ra08128e.
Wilar G, Suhandi C, Wathoni N, Fukunaga K, Kawahata I
Int J Nanomedicine. 2024; 19:11357-11378.
PMID: 39524925
PMC: 11550695.
DOI: 10.2147/IJN.S484838.
Luckenbach T, Burkhardt-Medicke K
Front Pharmacol. 2024; 15:1426040.
PMID: 39166110
PMC: 11333832.
DOI: 10.3389/fphar.2024.1426040.
Kaya B, Smith H, Chen Y, Azad M, Russell T, Richardson V
Chem Sci. 2024; .
PMID: 39165729
PMC: 11331336.
DOI: 10.1039/d4sc04339a.
Ramli I, Cheriet T, Thuan D, Khoi D, Thu D, Posadino A
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8231-8258.
PMID: 38842561
DOI: 10.1007/s00210-024-03180-x.
Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers.
Yang Y, Zhao C, Wang Z, Liu F, Zhao M, Yang H
Aging (Albany NY). 2024; 16(2):1696-1711.
PMID: 38261736
PMC: 10866448.
DOI: 10.18632/aging.205452.
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma.
Kumar D, Jain S, Coulter D, Joshi S, Chaturvedi N
Cancers (Basel). 2023; 15(24).
PMID: 38136401
PMC: 10741595.
DOI: 10.3390/cancers15245855.
The endocytic receptor protein LRP-1 modulate P-glycoprotein mediated drug resistance in MCF-7 cells.
Henry A, Mauperin M, Devy J, Dedieu S, Chazee L, Hachet C
PLoS One. 2023; 18(9):e0285834.
PMID: 37768946
PMC: 10538702.
DOI: 10.1371/journal.pone.0285834.
The blood-brain barrier: structure, regulation, and drug delivery.
Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y
Signal Transduct Target Ther. 2023; 8(1):217.
PMID: 37231000
PMC: 10212980.
DOI: 10.1038/s41392-023-01481-w.
What Is Known about Breast Cancer in Young Women?.
Zhu J, Charkhchi P, Adekunte S, Akbari M
Cancers (Basel). 2023; 15(6).
PMID: 36980802
PMC: 10047861.
DOI: 10.3390/cancers15061917.
Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis.
Jiang R, Cao M, Mei S, Guo S, Zhang W, Ji N
Front Oncol. 2022; 12:981406.
PMID: 36387132
PMC: 9641273.
DOI: 10.3389/fonc.2022.981406.
P-Glycoprotein (MDR1/ABCB1) Restricts Brain Accumulation of the Novel EGFR Inhibitor EAI045 and Oral Elacridar Coadministration Enhances Its Brain Accumulation and Oral Exposure.
Wang J, Susam M, Gan C, Sparidans R, Lebre M, Beijnen J
Pharmaceuticals (Basel). 2022; 15(9).
PMID: 36145346
PMC: 9505538.
DOI: 10.3390/ph15091124.
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches.
Emran T, Shahriar A, Mahmud A, Rahman T, Abir M, Siddiquee M
Front Oncol. 2022; 12:891652.
PMID: 35814435
PMC: 9262248.
DOI: 10.3389/fonc.2022.891652.
Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome.
Antony G, Augustine P, Parambil S, Littleflower A, Kattoor J, Krishna K
Clin Exp Med. 2022; 23(3):859-869.
PMID: 35810258
DOI: 10.1007/s10238-022-00852-x.
The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review.
Boughrara W, Chentouf A
Acta Neurol Belg. 2022; 122(4):871-880.
PMID: 35325436
DOI: 10.1007/s13760-022-01920-5.
Environmental antibiotics and resistance genes as emerging contaminants: Methods of detection and bioremediation.
Koch N, Islam N, Sonowal S, Prasad R, Sarma H
Curr Res Microb Sci. 2021; 2:100027.
PMID: 34841318
PMC: 8610363.
DOI: 10.1016/j.crmicr.2021.100027.
NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1- and ABCG2-Expressing Multidrug Human Cancer Cells.
Sinha B, Perera L, Cannon R
Cancers (Basel). 2021; 13(7).
PMID: 33918289
PMC: 8038154.
DOI: 10.3390/cancers13071680.
P-glycoprotein induction and its energetic costs in rainbow trout (Oncorhynchus mykiss).
Kennedy C
Fish Physiol Biochem. 2021; 47(2):265-279.
PMID: 33405060
DOI: 10.1007/s10695-020-00911-8.
Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim T, Tarini D, Dheen S, Bay B, Srinivasan D
Int J Mol Sci. 2020; 21(17).
PMID: 32842530
PMC: 7503838.
DOI: 10.3390/ijms21176070.
TRPS1 Confers Multidrug Resistance of Breast Cancer Cells by Regulating BCRP Expression.
Hu J, Zhang H, Liu L, Han B, Zhou G, Su P
Front Oncol. 2020; 10:934.
PMID: 32695669
PMC: 7338551.
DOI: 10.3389/fonc.2020.00934.
